Contraception

Oral Contraceptive Taytulla Recalled Due to Packaging Error

By May 29, 2018

A physician report indicates that 4 placebo (non-hormonal) capsules were placed in the first 4 days of therapy instead of active capsules.

Most Teens, Young Women Satisfied With IUD Insertion

May 18, 2018

The researchers found that 76.8% of the participants reported high overall satisfaction with the procedure and that 67.4% reported that they would recommend an IUD to a friend.

CDC: Number of US Births Dropped to 30-Year Low in 2017

May 17, 2018

For teenagers aged 15 to 19 years, the birth rate decreased 7% in 2017 to 18.8 births per 1,000 women, with decreases in the rates for younger and older teenagers (15 to 17 and 18 to 19, respectively).

Prescription Med Use in Children Down Overall From 1999 to 2014

May 16, 2018

Asthma medications, antibiotics, attention-deficit/hyperactivity disorder (ADHD) medications, topical agents, and antihistamines were the most commonly used medication classes in 2011 to 2014.

Emergency Contraceptive Preventeza Now Available Over-the-Counter

By May 08, 2018

Preventeza can be taken within 72 hours of unprotected sex or contraceptive failure although it is most effective the sooner it is taken.

Long-Acting Reversible Contraceptives Good for Teens

April 27, 2018

Patients' lack of familiarity with or understanding of these methods, potentially high cost of initiation, lack of access, low parental acceptance, and obstetrician-gynecologists' and other health care providers' misconceptions about LARC safety in adolescents are barriers to LARC use.

ACOG: Revised Committee Opinion on Postpartum Care Released

By April 25, 2018

Previously, ACOG had recommended a comprehensive postpartum visit occur within the first 6 weeks after birth.

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

April 25, 2018

During the same time period, birth rates declined for females aged 10 to 14 years for all race and Hispanic-origin groups, with non-Hispanic black females having the largest decline.

Number of IUD Insertions Up After ACA Contraceptive Mandate

April 10, 2018

"Women in plans with the greatest reduction in out-of-pocket cost after mandated coverage of contraception had the greatest gains in IUD insertion," the authors write.

FDA Puts New Restrictions on Permanent Birth Control Implant Essure

By April 09, 2018

The new Essure labeling restricts the sale and distribution of the device to only health care providers and facilities that provide information to patients about the risks and benefits of this device.

Male Birth Control Pill Moves 'Step Closer' Following Safety Trial

March 19, 2018

Suppression of follicle stimulating hormone and luteinizing hormone was reported for all subjects in the P400mg group and 12 of 13 subjects in the C400mg group. No significant change was seen in mood.

Progestin-Only Contraceptives and Depression: Is There a Link?

By February 28, 2018

Study quality was graded according to the United States Preventive Services Task Force and the Cochrane Risk of Bias Tools.

Toxic Plant Extract Shows Promise in Early Male Birth Control Studies

February 02, 2018

While the male hormonal birth control pill option is in clinical human trials and likely closer to market, it has several potential side effects: In addition to potentially causing weight gain and changes in libido.

Oral Contraceptive Balcoltra Gets FDA Approval

By January 17, 2018

Balcoltra is the only branded contraceptive that combines levonorgestrel 0.1mg and ethinyl estradiol 20mcg with ferrous bisglycinate 36.5mg.

Live-birth rates similar among ovulating women undergoing fresh- or frozen-embryo transfer

January 11, 2018

No differences were observed in live-birth rate, rates of implantation, clinical pregnancy, overall pregnancy loss, or ongoing pregnancy incidents between ovulatory women with infertility who received frozen-embryo or fresh-embryo transfers.

PMS/PMDD: A Review of Treatment Options

By January 04, 2018

Recent data regarding the treatment of premenstrual syndrome/premenstrual dysphoric disorder (PMS/PMDD) has "triaged therapy options into first, second, third, and last lines."

Few CA Pharmacies Offer RPh-Prescribed Contraception, Despite Law

By December 13, 2017

The law, enacted in 2013 and implemented in 2016, allows pharmacists to prescribe birth control to increase access to oral contraceptives, patches, rings, and injections for women.

Hormonal Contraceptives and Breast Cancer: What's the Link?

December 07, 2017

Findings from nationwide study in Denmark show small absolute increase in breast cancer risk

IUD Use and Cervical Cancer Risk: What's the Link?

By November 09, 2017

The data showed women who used IUD had a lower occurrence of cervical cancer (odds ratio [OR] 0.64, 95% CI: 0.53-0.77).

ACOG: Recommendations for LARC Initiation and Management

October 26, 2017

Insertion of IUD should be offered after first-trimester uterine aspiration, on same day as abortion

Lidocaine Found to Reduce Pain During IUD Insertion

September 11, 2017

Researchers randomized 95 adolescents and young women (ages 14 to 22) receiving a 13.5-mg levonorgestrel IUD to either a 10-mL 1% lidocaine paracervical block or a sham block.

Does Timing of Postpartum IUD Insertion Impact Breastfeeding Outcomes?

By September 07, 2017

Patients were randomized (1:1) to receive immediate device insertion postpartum (n=132) or delayed device insertion (n=127), which occurred 4-12 weeks postpartum

Oral Contraceptives May Reduce Rheumatoid Arthritis Risk

August 21, 2017

The researchers found that ever and past OC users had a reduced risk of anticitrullinated protein antibodies (ACPA)-positive RA compared with never users.

Targeting Premenstrual Breakthrough of Depression with OCs: Is it Effective?

By August 18, 2017

Premenstrual exacerbation (PME) of depression has been found to occur in roughly two-thirds of women with depressive disorders.

Contraindication Added to OCs, Other Ethinyl Estradiol-Containing Drugs

By August 10, 2017

The concomitant use of HCV drug combinations containing ombitasvir, paritaprevir/ritonavir, with or without dasabuvir is contraindicated due to the potential for liver enzyme elevations.

Dimethyl Fumarate and Oral Contraceptives: Drug Interactions Explored

By August 08, 2017

Delayed-release DMF exerts anti-inflammatory and neuroprotective properties for the treatment of relapsing multiple sclerosis, a disease that often develops in women between the ages of 20 and 40.

Liletta Approved to Prevent Pregnancy for up to Four Years

By August 07, 2017

The FDA's approval of the supplemental New Drug Application (sNDA) was based on efficacy and safety data from the ongoing Phase 3 ACCESS IUS trial.

ACOG: Recommendations for Counseling Teens About Contraception

July 27, 2017

Ob-gyns should address contraceptive needs, expectations, and concerns, regardless of patient age

Obtaining OTC Emergency Contraception May Still Be Tough for Teens

July 05, 2017

'Mystery shopper' study found pharmacists still refusing sales

CDC: Teen Birth Rates Reach Record Low

July 05, 2017

CDC researchers used birth records for nearly 100% of the births in the United States in 2016. The teen birth rate was 20.3 births per 1,000 female teens in 2016, compared to 41.5 births per 1,000 in 2007, according to the report.